Clinical Trial Update: A Study of KW-3357 in Congenital Antithrombin Deficiency [Phase 1]

View source ↗

Summary

This is a completed Phase 1 clinical trial evaluating KW-3357 in patients with congenital antithrombin deficiency.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Antithrombin Deficiency

Drugs mentioned

• KW-3357

Snippet

Sponsor: Kyowa Kirin Co., Ltd. | Conditions: Congenital Antithrombin Deficiency | Phase 1 | Status: COMPLETED